Suchergebnisse - "Touzeau, Cyrille"

PubPharm (231)

81

Paving the way to precision medicine in multiple myeloma

enthalten in: Expert review of hematology | 2021

von Inam, S. | Ross, J. | Touzeau, C. | +3

82

Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Chevallier, P. | Berceanu, A. | Peterlin, P. | +24

83

Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma

enthalten in: American journal of hematology | 2021

von Kaufman, J. | Gasparetto, C. | Schjesvold, F. | +18

84

Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES) : an open-label Phase II study

enthalten in: British journal of haematology | 2021

von Chari, A. | Rodriguez-Otero, P. | McCarthy, H. | +18

85

Carfilzomib in combination with daratumumab in the management of relapsed multiple myeloma

enthalten in: Future oncology (London, England) | 2021

von Touzeau, C. | Antier, C. | Moreau, P.

86

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Richardson, P. | Oriol, A. | Larocca, A. | +23

87

Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma : a single-center experience

enthalten in: Bone marrow transplantation | 2021

von Laurent, V. | Fronteau, C. | Antier, C. | +22

88

Fluctuating plasmacytosis in an immunocompetent woman leading a diagnosis of plasmablastic lymphoma

enthalten in: Annals of hematology | 2021

von Debord, C. | Bourcier, J. | Subiger, F. | +10

89

A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia

enthalten in: Cancer medicine | 2021

von Peterlin, P. | Gaschet, J. | Guillaume, T. | +20

90

Immune checkpoint inhibitors for the treatment of myeloma: novel investigational options

enthalten in: Expert opinion on investigational drugs | 2021

von Le Calvez, B. | Moreau, P. | Touzeau, C.